Job Description
The Cedars-Sinai Inflammatory Bowel Disease Institute (IBDI) in the Department of Medicine is seeking a Director to oversee operations and implement the IBDI vision.
The vison for IBDI is to create a world free of Inflammatory Bowel Diseases through world-class clinical care, excellence in translational research and promoting collaborative efforts to discover lasting solutions for patients. Working in a hybrid (on- and off-site) model reporting to the Executive Director of the Institute, the Director of Operations for IBDI is responsible for managing and expanding Institute capabilities to fulfill IBDI objectives.
Responsibilities include:
- building and integrating institutional research partnerships
- recruiting research faculty and integrating them in the IBDI
- overseeing grant management for the IBDI
- managing Institute resources, including the MIRIAD Biobank and data repository
- promoting optimal collaboration and communication within the Institute, Institution and to external partners to successfully achieve IBDI deliverables
- ensuring compliance with institutional, state and federal regulations, in particular, with respect to human subjects.
The Director of Operations will implement standards for organizational structure and governance as well as process improvements to maximize IBDI impact.
Cedars-Sinai Medical Center is one of the largest and fastest-growing non-profit academic medical centers in the U.S. Discovery is a core value to Cedars-Sinai’s mission. The institution’s laboratories and clinics generate ideas, therapies, devices and systems that contribute to biomedical progress around the world. More than 2,000 current research projects explore the full breadth of biomedical research. Examples include investigating how high-fat diets may promote liver cancer as well as the effects of near weightlessness on iPSCs in conjunction with NASA, connections among diabetes and chronic pancreatitis and pancreatic cancer, and the genetic underpinnings of disease, exploiting the potential of stem cells, leveraging nanotechnology, parsing big data, and assessing how gender and metabolism impact health. During the last five years, Cedars-Sinai has doubled its federal awards. Cedars-Sinai’s FY23 federal awards totaled $158 million (an increase of 22% from FY22) and $261 million in research expenses (an increase of 12.5% from FY22).
Our compensation philosophy:
We offer competitive total compensation that includes pay, benefits, and other incentive programs for our employees. The total pay range shown takes into account the wide range of factors that are considered in making compensation decisions including knowledge/skills; relevant experience and training; education/certifications/licensure; and other business and organizational factors. This total pay range includes any incentive payments that may be applicable to this role. We also offer a comprehensive faculty benefits package.
Pay Range: $165,547-$450,008 Total Cash Compensation
Qualifications
Qualifications include:
- Doctorate (MD or PhD) with greater than 10 years’ experience in translational (bench-to bedside/ bedside-to-bench) research.
- Demonstrated management experience in a complex academic or multi-site/multi-disciplinary environment required.
- Strong leadership skills with demonstrated success in building a collaborative team environment.
- Strong negotiation and interpersonal skills.
- Experience in managing a biorepository or biobank preferred.
- Master’s degree in operations management, project management, strategic management, business management, or similar experience is desirable.
- Working knowledge of grants and contract administration.
About Us
About the Team
Diversity and Inclusion at Cedars-Sinai
We are caretakers and innovators committed to the pursuit of equitable healthcare. But health equity is not possible without representation. Our commitment to diversity goes beyond demographics or checking boxes. Our people must reflect the diverse identities, experiences and geographies of the communities and patients we serve – because that’s what our patients, colleagues and communities deserve. Quality Care and Research—For All, By All (opens in new window).
Cedars-Sinai is an Equal Employment Opportunity employer.
Cedars-Sinai does not unlawfully discriminate on the basis of the race, religion, color, national origin, citizenship, ancestry, physical or mental disability, legally protected medical condition (cancer-related or genetic characteristics or any genetic information), marital status, sex, gender, sexual orientation, gender identity, gender expression, pregnancy, age (40 or older), military and/or veteran status or any other basis protected by federal or state law. If you need a reasonable accommodation for any part of the employment process, please contact us by email at Applicant_Accommodation@cshs.org and let us know the nature of your request and your contact information. Requests for accommodation will be considered on a case-by-case basis. Please note that only inquiries concerning a request for reasonable accommodation will be responded to from this email address.
Cedars-Sinai will consider for employment qualified applicants with criminal histories, in accordance with the Los Angeles Fair Chance Initiative for Hiring.
At Cedars-Sinai, we are dedicated to the safety, health and wellbeing of our patients and employees. This includes protecting our patients from communicable diseases, such as influenza (flu) and COVID-19. For this reason, we require that all new employees receive a flu vaccine based on the seasonal availability of flu vaccine (typically during September through April each year) as a condition of employment, and annually thereafter as a condition of continued employment, subject to medical exemption or religious accommodation. For the same reason, you may also be required to receive other vaccines such as COVID-19 as a condition of employment. Cedars-Sinai reserves the right to make modifications to its required list of vaccines as required by law and/or policy. Cedars-Sinai’s AA Policy Statement (PDF) (opens in new window)